EUVIMEDEUVIMED entdecken
Übersichtsarbeit

QT Prolongation and Arrhythmias in Cancer Therapy: A Narrative Review of Mechanistic and Clinical Studies

Kayode E Ogunniyi iD, Trie Arni Djunadi iD, Samuel Abiola Ayedun iD, Victor Onyenokwe iD, Oghenevwede Anderson Okuma iD, Eric Sanji iD, Andrew Greek iD

Cardiovascular Toxicology · 2026-06 · 26 (6)

DOI: 10.1007/s12012-026-10130-x ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiovascular Toxicology, online erschienen am 23.05.2026. Verfasst von Kayode E Ogunniyi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Richmond University Medical Center/Mount Sinai, 355 Bard Ave, Staten Island, NY, 10310, USA. drkayodeogunniyi@gmail.com. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms, Long QT Syndrome, Heart Rate. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 124 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug-induced QTc prolongation has emerged as a major, preventable cause of malignant ventricular arrhythmias in cancer therapy. This narrative review integrates mechanistic, clinical, and practical insights into QTc prolongation associated with antineoplastic and supportive medications. We outline direct ionic mechanisms, most notably hERG/IKr blockade and PI3K/Akt pathway modulation, as well as indirect contributors, including cytokine-mediated myocarditis, electrolyte disturbances, and structural remodeling. High-risk agents, including arsenic trioxide, vandetanib, nilotinib, sunitinib, and ribociclib, are contrasted with lower-risk alternatives and QT-sparing strategies. Polypharmacy and drug-drug interactions are emphasized as major real-world amplifiers of risk. Among supportive medications, fluoroquinolones, azole antifungals, and certain antiemetics frequently interact with QT-active anticancer agents, whereas beta-lactams, echinocandins, isavuconazole, and palonosetron may represent safer alternatives. We propose a mechanism-to-bedside framework that incorporates baseline ECG and electrolyte assessment, QT-risk stratification, and clear intervention thresholds (QTc ≥ 500 ms or an increase of ≥ 60 ms). Acute management of torsades de pointes, including intravenous magnesium and overdrive pacing, as well as structured hold-and-rechallenge algorithms, is also summarized. Finally, we highlight system-level measures, such as drug interaction stewardship, standardized discharge communication, and clinician education, to shift cardio-oncology practice from reactive arrhythmia management toward anticipatory prevention. This integrative synthesis aims to preserve oncologic efficacy while mitigating arrhythmic risk in modern cancer care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsLong QT SyndromeHeart RateArrhythmias, CardiacAction PotentialsHeart Conduction SystemHumansAnimalsRisk FactorsCardiotoxicityDrug InteractionsRisk AssessmentAnti-Arrhythmia Agents

Stichwörter der Autor:innen

Cardio-oncologyDrug–drug interactionsPolypharmacyQT prolongationTorsades de pointesTyrosine kinase inhibitorshERG/IKr

Substanzen

Antineoplastic AgentsAnti-Arrhythmia Agents

Autor:innen und Institutionen

  • Richmond University Medical Center/Mount Sinai, 355 Bard Ave, Staten Island, NY, 10310, USA. drkayodeogunniyi@gmail.com.
  • Royal College of Physicians, London, UK. drkayodeogunniyi@gmail.com.
  • Richmond University Medical Center/Mount Sinai, 355 Bard Ave, Staten Island, NY, 10310, USA.
  • Montefiore Medical Center, New York, USA.
  • Royal Infirmary Edinburgh Hospital, Edinburgh, UK.
  • James Cook University Hospital, Middlesbrough, UK.

ORCID-Profile: Kayode E Ogunniyi, Trie Arni Djunadi, Samuel Abiola Ayedun, Victor Onyenokwe, Oghenevwede Anderson Okuma, Eric Sanji, Andrew Greek

Zitieren

APA

Ogunniyi, K. E., Djunadi, T. A., Ayedun, S. A., Onyenokwe, V., Okuma, O. A., Sanji, E., & Greek, A. (2026). QT Prolongation and Arrhythmias in Cancer Therapy: A Narrative Review of Mechanistic and Clinical Studies. Cardiovascular Toxicology, 26(6). https://doi.org/10.1007/s12012-026-10130-x

Vancouver

Ogunniyi KE, Djunadi TA, Ayedun SA, Onyenokwe V, Okuma OA, Sanji E, et al. QT Prolongation and Arrhythmias in Cancer Therapy: A Narrative Review of Mechanistic and Clinical Studies. Cardiovascular Toxicology. 2026;26(6). doi:10.1007/s12012-026-10130-x

BibTeX
@article{Ogunniyi2026,
  author = {Ogunniyi, Kayode E and Djunadi, Trie Arni and Ayedun, Samuel Abiola and Onyenokwe, Victor and Okuma, Oghenevwede Anderson and Sanji, Eric and Greek, Andrew},
  title = {QT Prolongation and Arrhythmias in Cancer Therapy: A Narrative Review of Mechanistic and Clinical Studies},
  journal = {Cardiovascular Toxicology},
  year = {2026},
  volume = {26},
  number = {6},
  doi = {10.1007/s12012-026-10130-x}
}
Kostenlos starten →